Biotechnology Breakthroughs ETFs

Biotechnology Breakthroughs ETFs
  • Pininvest Analysis

Because R&D in biotechnology is complex and the rate of drug approval remains uncertain, investment strategies followed by ETFs adopt two distinct models

  • broad based funds cast a wide net, as poor performing clinical-stage companies could become tomorrow's stars  - with more than 190 holdings, iShares fund IBB/NASDAQ limits risk exposure through diversification 
  • focused funds, targeting break-through technologies, advanced treatments of rare diseases or clinical-stage research, accept high risk exposure (volatility) in the hope of above average performance 

Including funds based on either models as well as leveraged funds, the theme is benchmarked with the iShares NASDAQ Biotechnology ETF IBB/NASDAQ 

Our ETF market sector themes present a cross-sectional view of equity trends – in terms of market coverage, size and style. We hope to achieve a fair coverage of ETFs in each category, which is a work in progress

We do not receive any commission or other form of compensation from the providers included in our 'Funds' presentation

Biotechnology Breakthroughs ETFs • Updated:

Name Ticker Exchange Category SubCategory Currency Cur.Price AUM Perf. Vol. Risk Contrib. MDD
 
ALPS Medical Breakthroughs SBIO NYSEARCA US Market 21st Century Focus USD 41.47 216 M 16.6% 43%   8% -39%
ARK Invest Genomic Revolution Multi-Sector ETF ARKG BATS Health Care Biotech USD 56.18 538 M 72.8% 47%   8% -35%
Direxion Daily S&P Biotech Bull 3X Shares LABU NYSEARCA Health Care Biotech USD 60.40 321 M 36.9% 117%   22% -77%
First Trust NYSE Arca Biotechnology Index Fund FBT NYSEARCA Health Care Biotech USD 166.33 1.7 B 21.2% 31%   6% -27%
Invesco Dynamic Biotechnology & Genome ETF PBE NYSEARCA Health Care Biotech USD 61.17 213 M 15.1% 34%   6% -31%
iShares Evolved US Innovative Healthcare ETF IEIH BATS Health Care Biotech USD 30.68 5.3 M 23.7% 26%   5% -22%
iShares Nasdaq Biotechnology IBB NASDAQ by Sector Health Care USD 136.23 7.0 B 29.0% 31%   6% -24%
Loncar Cancer Immunotherapy ETF CNCR NASDAQ Health Care Biotech USD 26.19 38 M 27.5% 39%   6% -35%
Market Vectors Biotech ETF BBH NASDAQ Health Care Biotech USD 164.12 334 M 30.5% 29%   5% -21%
Principal Healthcare Innovators Index ETF BTEC NASDAQ Health Care Biotech USD 45.81 57 M 34.6% 37%   7% -36%
ProShares Ultra Nasdaq Biotechnology BIB NASDAQ Leveraged by Sector USD 71.52 152 M 47.5% 65%   12% -45%
ProShares UltraPro Nasdaq Biotechnology UBIO NASDAQ Leveraged by Sector USD 17.61 20 M -24.2% 68%   10% -58%
ProShares UltraPro Short Nasdaq Biotechnology ZBIO NASDAQ Inverse by Sector USD 10.09 3.7 M -30.2% 72%   -10% -54%
ProShares UltraShort Nasdaq Biotechnology BIS NASDAQ Inverse by Sector USD 7.95 22 M -54.7% 62%   -11% -67%
SPDR S&P Biotech ETF XBI NYSEARCA Health Care Biotech USD 113.92 3.9 B 34.4% 39%   7% -33%
Virtus LifeSci Biotech Clinical Trials ETF BBC NYSEARCA Health Care Biotech USD 41.33 32 M 52.2% 44%   8% -40%
Virtus LifeSci Biotech Products ETF BBP NYSEARCA Health Care Biotech USD 45.90 25 M 18.8% 35%   6% -30%